A single chromosome 3p break initiates clear cell renal cell carcinoma evolution

Technical Summary: A Single Chromosome 3p Break Initiates Clear Cell Renal Cell Carcinoma Evolution

Problem Statement
Clear cell renal cell carcinoma (ccRCC) is universally characterized by the loss of the short arm of chromosome 3 (3p), which results in the heterozygous loss of four major tumor suppressor genes: VHL, PBRM1, BAP1, and SETD2. However, a fundamental paradox exists in cancer biology: aneuploidy, particularly chromosome loss, typically imposes a severe fitness burden on normal cells due to genotoxic, proteotoxic, and metabolic stress. It remains unclear how renal epithelial cells tolerate this deleterious state during early tumorigenesis, how the specific rearrangement patterns of 3p loss arise, and whether the recurrent secondary aneuploidies observed in ccRCC (specifically 5q gain and 14q loss) are stochastic byproducts of genomic instability or deterministic adaptive responses. Furthermore, existing mouse models fail to faithfully recapitulate human ccRCC genetics because the four 3p tumor suppressors reside on separate chromosomes in mice, and the fitness costs of aneuploidy have hindered the modeling of early cancer initiation in normal human cells.

Methodology
The authors employed a multi-faceted approach combining large-scale genomic analysis with a novel human cell-based model:

1. Genomic Analysis: The authors analyzed whole-genome sequencing (WGS) data from 949 ccRCC tumors (from Senkin et al. and TCGA) and 7,830 pan-cancer genomes to characterize the structural variants (SVs) underlying 3p loss. They utilized tools such as ShatterSeek, LINX, and PURPLE to identify chromothripsis signatures and define specific rearrangement patterns.
2. Cell Line Engineering: They utilized hTERT-immortalized, non-transformed human renal proximal tubule epithelial cells (RPTECs), the putative cell of origin for ccRCC. To overcome slow proliferation and facilitate clonal isolation, they expressed CDK4. To bypass the immediate p53-dependent cell cycle arrest and apoptosis triggered by aneuploidy, they suppressed p53 using shRNA.
3. Induction of 3p Loss: Using CRISPR-Cas9 ribonucleoprotein (RNP) complexes, they induced a targeted double-strand break (DSB) on chromosome 3p near recurrent breakpoint regions. This was designed to mimic the initiating event of ccRCC.
4. dTAG-Flow Strategy: To isolate the rare cells that survived 3p loss (which are strongly counter-selected), the authors developed a functional enrichment strategy. They expressed a GFP-degron fusion protein dependent on pVHL for degradation. Since 3p loss reduces pVHL dosage, these cells retain GFP fluorescence upon treatment with the degrader dTAGv1, allowing for Fluorescence-Activated Cell Sorting (FACS) of 3p-loss clones.
5. Longitudinal Evolution and Characterization: Isolated clones were serially passaged for up to 180 days. Their genomic evolution was tracked via metaphase FISH, Oligopaint FISH, and WGS. Transcriptional responses were analyzed via single-cell and bulk RNA sequencing. Metabolic phenotypes were assessed using Seahorse analysis, and tumorigenic potential was evaluated via soft agar assays and subcutaneous xenografts in immunocompromised mice.

Key Contributions and Results

• Breakpoint-Confined Chromothripsis: Analysis of ccRCC genomes revealed a recurrent rearrangement pattern termed "breakpoint-confined chromothripsis." Unlike canonical chromothripsis which affects large chromosomal regions, this pattern involves clustered SVs confined to a small genomic region (<14.7 Mbp) immediately adjacent to the terminal 3p breakpoint. This pattern is highly enriched in ccRCC (35% of 3p loss events) compared to other cancers.
• Mechanism of Initiation: The engineered DSB in RPTECs recapitulated the human disease spectrum. It generated both simple arm-level deletions and, through sister chromatid fusion and chromatin bridge fragmentation, breakpoint-confined chromothripsis. This demonstrated that a single initiating DSB is sufficient to generate the complex rearrangement signatures observed in patient tumors.
• Fitness Bottleneck and Adaptive Evolution: 3p loss imposed a severe fitness burden, leading to oxidative stress-induced senescence. Cells survived this bottleneck only by acquiring specific compensatory alterations. The authors observed that surviving clones recurrently and convergently acquired chromosome 5q gain and chromosome 14q loss.
• Role of 5q Gain and 14q Loss:
  • 5q Gain: Often coupled with 3p loss via translocation, 5q gain conferred a selective advantage. The study identified SQSTM1 (p62), located on 5q, as a critical mediator. While p62 levels were elevated in 3p loss clones regardless of 5q copy number, its functional necessity was confirmed as SQSTM1 knockout abolished anchorage-independent growth.
  • 14q Loss: This was the most consistent evolutionary endpoint, occurring in all late-passage clones. It conferred a proliferative advantage and was associated with metabolic reprogramming, specifically enhanced mitochondrial respiration (OXPHOS) and mTORC1 signaling. The loss of HIF1A (on 14q) was proposed as a mechanism to alleviate growth restraint, shifting the balance toward pro-tumorigenic HIF2α signaling.
• Malignant Transformation: Late-passage clones, having accumulated 3p loss, 5q gain, and 14q loss, successfully formed xenograft tumors in mice within ~120 days and exhibited spontaneous lung metastasis. Notably, these tumors formed despite the retention of the remaining VHL allele and without the canonical diffuse HIF2α activation seen in established ccRCC, suggesting that the stepwise accumulation of adaptive aneuploidies drives tumorigenesis prior to complete VHL inactivation.

Significance
The paper claims to resolve the paradox of how a deleterious initiating event (chromosome 3p loss) can drive tumorigenesis. It posits that 3p loss acts not as an immediate oncogenic driver but as a "fitness bottleneck" that creates a selective environment. Only rare lineages that acquire specific, recurrent adaptive aneuploidies (5q gain and 14q loss) can escape this bottleneck.

The study provides direct experimental evidence that:

1. A single chromosome break can initiate the evolutionary trajectory of ccRCC.
2. Recurrent aneuploidies in ccRCC are deterministic adaptations to the fitness costs of 3p loss, rather than stochastic consequences of genomic instability.
3. Metabolic reprogramming (enhanced OXPHOS and mTORC1 activation) is a key driver of the malignant progression following these chromosomal alterations.

By establishing a genetically defined isogenic model, the authors provide a platform to study the earliest stages of ccRCC evolution, demonstrating that tumor initiation reflects an evolutionary escape from a growth-suppressive state driven by stepwise chromosomal evolution.